MIT Technology Review recently covered research by Colin Buss, a graduate researcher at the Bhatia Lab. You can read the article here.
Excerpt: Colin was inspired by the work of bioengineering professor Sangeeta Bhatia, SM ’93, PhD ’97, who was developing cancer diagnostics and therapeutics that made frequent use of nanoparticles as a delivery technology. Buss had studied chemical engineering at Cornell and initially considered becoming a doctor, but he realized he was more interested in medical research. Eager to help expand Bhatia’s nanoparticle technology into new areas of application, like targeting cells of the immune system, he joined her Laboratory for Multiscale Regenerative Technologies at the Koch Institute five years ago. His research there as a doctoral student has pushed him to tap into his inner engineer, he says, to “come up with a solution to some really interesting question.”